Hepatitis C
Conditions
Interventions
Hepatitis C patients:Polydiethanol Interferon Alpha-2a Treatment
Sponsors
The First Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) All patients were not treated with interferon and immunomodulator before admission; (2) Patients did not undergo liver or spleen surgery before admission; (3) All patients had no contraindication diseases of interferon and ribavirin.
Exclusion criteria
Exclusion criteria: (1) Patients with incorporated hepatitis A, hepatitis B and other hepatitis virus infections; (2) Patients with drug-induced hepatitis, alcoholic hepatitis, metabolic hepatitis and other types of hepatitis; (3) Patients upon admission to the hospital with liver decompensation or progression to cirrhosis and liver cancer after imaging and pathological examination; (4) Patients with combining major basic diseases such as circulation, respiration, and endocrine diseases; (5) Patients combined with HIV, Epstein-Barr virus and other viral diseases which can affect detection index.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HCV RNA;Liver tissue biopsy;MRI image; | — |
Secondary
| Measure | Time frame |
|---|---|
| IL-12;IL-10; | — |
Countries
China
Contacts
Public ContactZHANG Yan-Zhen
The First Affiliated Hospital of Zhengzhou University
Outcome results
None listed